Nakanishi Inc. (TYO:7716)
Japan
· Delayed Price · Currency is JPY 2,058.00
+38.00 (1.88%)
Mar 10, 2025, 3:30 PM JST
Nakanishi Revenue
In the year 2024, Nakanishi had annual revenue of 77.04B JPY with 29.06% growth. Nakanishi had revenue of 20.42B in the quarter ending December 31, 2024, with 10.52% growth.
Revenue
77.04B
Revenue Growth
+29.06%
P/S Ratio
2.32
Revenue / Employee
37.60M
Employees
2,049
Market Cap
178.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 77.04B | 17.35B | 29.06% |
| Dec 31, 2023 | 59.69B | 11.02B | 22.64% |
| Dec 31, 2022 | 48.67B | 3.81B | 8.50% |
| Dec 31, 2021 | 44.86B | 11.80B | 35.70% |
| Dec 31, 2020 | 33.06B | -2.36B | -6.67% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |